🟢 Insmed is trading 4.51% up in pre-market amid broad market gains

Insmed is trading at $125.41 in pre-market, up +4.51%, likely helped by a broad risk-on market lift.

• No clear company-specific announcement was identified for September 21, 2026; recent coverage centers on earlier investor conferences and BRINSUPRI growth.
• The S&P 500 is up 0.74% and NASDAQ is up 1.11%, supporting a likely global risk-on lift.
• Recent negative commentary about BRINSUPRI uptake appears stale and does not directly explain the rebound.